ArticleKnee surgery, sports traumatology, arthroscopy : official journal of the ESSKA2026
The substantial economic burden of rotator cuff pathology: A nationwide cost-of-illness study.
Article in Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
purposeThe purpose of this study is to evaluate the nationwide economic burden of rotator cuff (RC) pathology by quantifying expenditures related to outpatient consultations including out-of-pocket expenses, hospitalisations and occupational insurance claims, within a national healthcare system.
methodsTo estimate outpatient costs and to analyse hospital admissions with a primary or secondary diagnosis related to RC pathology, data from 2017 to 2023 were retrieved from the Italian Ministry of Health outpatient specialist care database and SDO database, respectively. Data from INAIL's statistical archives was extracted focusing exclusively on recognised cases of occupational disease between 2019 and 2023. Descriptive statistics were used to summarise annual service volumes, costs and data trends.
resultsOutpatient service costs for a standard conservative treatment in the year 2023 amounted to approximately €1.7 billion. Theoretical remuneration for hospital discharges with primary diagnoses related to shoulder and RC pathologies revealed an annual expenditure for the year 2023 of €111 million and a total expenditure of €739 million from 2017 to 2023. These costs, based on diagnosis-related group (DRG) reimbursements, explicitly include all surgical expenses. Based on INAIL data, the average cost per occupational shoulder disease case for 2024 was estimated at approximately €25,700 per worker, and over 5 years, several €100 million were spent.
conclusionThe annual economic burden of RC pathology in Italy exceeds €2 billion yearly, coming from private and public spending related to conservative outpatient treatment services, hospital admissions and expenditure for work-related injuries. This figure provides a lower-bound estimate of the total economic burden, and future cost-analysis would benefit from consideration of indirect and physiotherapy-related costs. LEVEL OF EVIDENCE: Level III.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.